Professor  |  Dean, Faculty of Medicine

Trevor Young

Neurosciences and Clinical Translation
Office of the Dean, Faculty of Medicine, University of Toronto Medical Sciences Building
1 King's College Circle, 2109, Toronto, Ontario Canada M5S 1A8
Appointment Status

Dr. Young was appointed Chair, Department of Psychiatry effective September 1, 2010. He received his medical degree at the University of Manitoba. This was followed by residency training at McGill University and the University of Toronto where he also completed his PhD in Medical Sciences. He completed a Research Fellowship at Johns Hopkins University. His former roles include Physician-in-Chief, Executive Vice President Programs at the Centre for Addiction and Mental Health, Professor and Cameron Wilson Chair in Depression Studies in the Department of Psychiatry at the University of Toronto, and Professor and Head, Department of Psychiatry, University of British Columbia. He was received numerous awards including the Douglas Utting Award for outstanding contributions in the field of mood disorders, the Canadian College of Neuropsychopharmacology Heinz Lehmann Award, and is a Distinguished Fellow of the American Psychiatric Association. He has led several large clinical programs including the Mood Disorders Program at Hamilton Psychiatric Hospital, which received the American Psychiatric Services Gold Achievement Award. In 2009, he was elected as a Fellow of the Canadian Academy of Health Sciences.

Dr. Young serves as the Dean of the Faculty of Medicine, University of Toronto, effective January 1, 2015



Research Synopsis


As an active clinician scientist, Dr. Young's principal research interest includes understanding the molecular basis of bipolar disorder and its treatment, and how to apply these findings to the clinical setting. He is widely published and well funded by peer-reviewed granting agencies. His research is particularly focused on understanding the processes that lead to long-term changes in brain structure and function in patients with bipolar disorder and how these changes can be targeted by mood stabilizing drugs.